Quick Search:       Advanced Search
Chinese Version 
Online office
Journal Online
Download
Top
Links

扫描微信二维码,获取更多信息
Clinical studies on treatment of acute cerebral infarction with Xueshuantong injection
  
View Full Text  View/Add Comment  Download reader
KeyWord:Xueshuantong  acute cerebral infarction  tissue type plasminogen  plasminogen inhibitor  D-D dimmer  antithrombin-III  fibrinogen
Author NameAffiliation
Du Jin-hang China-Japan Friendship Hospital, 100029, Beijing 
Ren Zai-fang China-Japan Friendship Hospital, 100029, Beijing 
Shi Zai-xiang China-Japan Friendship Hospital, 100029, Beijing 
Huang Li China-Japan Friendship Hospital, 100029, Beijing 
Hits: 1016
Download times: 478
Abstract:
      Objective: To observe the effect of Xueshuantong injection (XST, with its ingredient as Notoginseng saponin, on acute cerebral infarction (ACI) and on blood coagulation and fibrinolysis, so as to comprehensively analyse the mechanism of XST.Methods: Fifty ACI patients were randomly divided into 2 groups, and XST group (30 patients) was treated with XST, and the control group (20 patients) given low molecular dextrose, as well as low molecular heparin calcium. The course of treatment for both groups was 15 days. The changes of effective rate, score of neurologic impairment, tissuetype plasminogen activator (tPA), inhibitor of plasminogen activator (PAI), D-D dimmer, antithrombinIII (AT-III), and fibrinogen (Fbg) were all observed.Results: The total effective rate of XST group was 73.33%, that of the control group 65. 00%. After the therapy, plasma level of tPA, ratio of tPA/PAI, and AT-III content were increased obviously, while the plasma level of PAI and D-D dimmer were decreased significantly (all P<0.01). But there was only insignificant difference between the 2 groups (P> 0.05).Conclusion: XST injection could be effective to ACI, the mechanism of which is probably related to improving the balance between plasminogen activator and its inhibitory factor, increasing the activity of fibrinolysin, inactivating thrombin, inhibiting platelet aggregation induced by thrombin, and decreasing blood coagulation.
Close